TDO2 and hepatocellular carcinoma: In this study, we firstly used UALCAN (http://ualcan.path.uab.edu) to conveniently access clinical data from TCGA for an analysis of the differences in TDO2 mRNA levels between normal samples and HCC as well as their relationship to clinicopathological parameters [18].